(Date:1/8/2009)...ts stage for productive partnership , , BALTIMO...ecovery Coalition (MARC), a broad-based group to a...the groundwork for improving the Medicare Secondar...th officials from the Center for Medicare and Medi...troduce MARC as an industry resource to CMS and of...
(Date:1/8/2009)... cultural differences of native peoples , ...vidence suggests that two different waves of peopl...ame time to become the first settlers in the Ameri... to 17,000 years ago, one group of people came to ...e connected northeast Siberia to Alaska, and moved...
(Date:1/8/2009)...Newswire/ -- Advantage Capital Partners, a leading... today announced that it has,provided $4.6 millio...uisiana.,The funding, raised in connection with t...l allow Morehouse General Hospital in Bastrop to a... and buy critical new x-ray, MRI and CT scan,equi...
(Date:1/8/2009)...arrow into releasing extra adult stem cells into t...ne day be used to repair heart damage or mend a br...ournal Cell Stem Cell . , When a person has a ...fferent types of stem cells to help repair and reg...rom Imperial College London, shows that it may be ...
Breaking Medicine News(10 mins):Health News:MARC Coalition Holds Initial Meeting With CMS; Announces New Members 2Health News:First Americans Arrived on 2 Separate Paths 2Health News:New Markets Development Program Brings Renovations, Equipment to Bastrop, Louisiana Hospital 2Health News:New Markets Development Program Brings Renovations, Equipment to Bastrop, Louisiana Hospital 3Health News:Scientists call up stem cell troops to repair the body using new drug combinations 2Health News:Scientists call up stem cell troops to repair the body using new drug combinations 3... became sick and one death was reported after bein...ording to reports about 2,500 children in the east...tis A vaccine on the 16 and 17 of June without off... child suffered an unspecified infection and breat...
...egranate juice will significantly delay the develo... the time it takes for prostate specific antigen (...umour activity and thus check the severity of the ...lent in men is prostate cancer. It affects a large...
...educe the risk of cellular rejection after a heart...uppression. The drug, a humanized monoclonal antib...r, thereby inhibiting T-cell proliferation. Patien...n into the Study were either given daclizumab or a...
...nial Magnetic Stimulation' (TMS) maybe the way fo...gressive electro-shock therapy. Electro-Shock Ther...ort to treat severe depression for many decades. H...air memory for weeks after therapy and requires ge...
Other Medicine News:Health News:Strong Magnetic Stimulation Can Help Treating Severe Depression 2(Date:1/7/2009)... 7 ImQuest Life Sciences announced...tion to the Food and Drug Administration to initia...dione HIV inhibitor IQP-0410. ImQuest anticipates ...ter of 2009. IQP-0410 is a novel small molecule in...side reverse transcriptase inhibitor (NNRTI). The ...
(Date:1/7/2009)... January 7 Circassia Ltd, a specia...and critical care, today,announced that following...,its ToleroMune(R) anti-allergy technology, the c...a further phase II clinical trial in cat allergy. ...ited 120 patients with confirmed,cat allergies, a...
(Date:1/6/2009)...6 In recent controlled studies con...his , scientists found that the patented ingredien... only proven ingredient to increase levels of nitr...d nitrate/nitrate (NOx) in human subjects. , , ...increase in blood flow to the skeletal muscles. T...
(Date:1/6/2009)...n. 6 Cequent Pharmaceuticals, a pi...ver RNAi-based treatments to prevent and treat hum...y completed a successful toxicology study of its c...herapeutic targeting the primary oncogene (beta-ca...sis). FAP is an inherited gastrointestinal disease...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3New FIRST RESPONSE 28R 29 Home Ovulation Test Takes the Guesswork Out of Conception 11757 1New FIRST RESPONSE 28R 29 Home Ovulation Test Takes the Guesswork Out of Conception 11757 2New FIRST RESPONSE 28R 29 Home Ovulation Test Takes the Guesswork Out of Conception 11757 3New FIRST RESPONSE 28R 29 Home Ovulation Test Takes the Guesswork Out of Conception 11757 4New FIRST RESPONSE 28R 29 Home Ovulation Test Takes the Guesswork Out of Conception 11757 5Barrier Technology Provides New Weapon in MRSA War 3A Surface Care Products Prevent Growth and Transfer of Bacteria 11752 1Barrier Technology Provides New Weapon in MRSA War 3A Surface Care Products Prevent Growth and Transfer of Bacteria 11752 2Geisinger study 3A PTSD a medical warning sign for long term health problems 11749 1Geisinger study 3A PTSD a medical warning sign for long term health problems 11749 2Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 1Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 2Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 3Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 4Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 5Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement 3243 6... 12, 2007--The costs of eradicating,poliomyelitis ...in,the short term, are much lower than the long te...radication. And a recently developed,monovalent va...,type 1 poliomyelitis than an existing trivalent v...lished Online and in an upcoming,issue of The Lanc...
...ation at EASL on April 13, 2007, 2007, SAN DIEGO, ...Call/ -- Anadys Pharmaceuticals, Inc. and LG Life,...udy showing that,ANA380 (LB80380) retains potency ...us (HBV) which are resistant to lamivudine,adefov...entation at,the 42nd Annual Meeting of the Europea...
Other Medicine Technology:Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6... in providing versatile liquid handling platforms ...livers even more flexibility and possibilities for...er with the new easy-to-use software, Freedom EVOw...te genomics, proteomics, and drug discovery applic...
...om DePuy offers a comprehensive combination of com...ecommendations regarding occupational exposure to ...rd for comfort. , ,The PROVISION System is de...htweight, hose-free, bicycle helmet design. , ,...
...rpness and efficiency with an innovative and compr...asty. Advanced trephine blade technology provides...ritical fit needed for successful transplants. Th...tem enables surgeons to select the style and size ...
Misys Laboratory is a comprehensive, high-performance, information system that manages specimen data from requisition entry through specimen tracking to final cumulative report production. Misys Labo
Medicine Products: